Skip to content

A single center, cross-sectional study of dry eye condition in patients who wear cwear orthokeratology lenses

A single center, cross-sectional study of dry eye condition in patients who wear cwear orthokeratology lenses

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600120607
Enrollment
Unknown
Registered
2026-03-17
Start date
2025-03-12
Completion date
Unknown
Last updated
2026-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dry eye

Interventions

Observation group:None

Sponsors

Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
8 Years to 16 Years

Inclusion criteria

Inclusion criteria: 1. Age 8~16 years old (including 8 years old and 16 years old), male or female; 2. Those who have confirmed myopia with clinical diagnosis, completed routine orthokeratology endoscopy, and wore and followed up regularly; 3. The guardian voluntarily signed the "Informed Consent Form of the Subject".

Exclusion criteria

Exclusion criteria: 1. History of severe allergies, glaucoma, blue eyelids syndrome, ocular hypertension, fundus macular lesions or lesions, etc., do not meet the requirements for wearing orthokeratology lenses; 2. Corneal curvature examination, the average K value of the anterior surface of the cornea >=45; 3. Patients with heart, liver, kidney and other systemic diseases and congenital hereditary myopia; 4. Patients with ocular trauma and chronic eye diseases such as oblique or surgical eye and atopic keratoconjunctivitis; 5. Patients with other eye diseases such as varus trichiasis, severe horn and conjunctival infections; 6. Patients with neurological diseases and allergies or contraindications to atropine drugs or other therapeutic drugs; 7. Patients with albinism, psoriasis, nephrotic syndrome, systemic lupus erythematosus, diabetes and other immune system and systemic diseases; 8. Epilepsy, mental disorders and unable to communicate normally; 9. Those who have received other treatments to control the development of myopia in the past, such as the use of anticholinergic drugs such as atropine within 3 months, or participated in other functional frames, multifocal flexible scopes and other related investigators; 10. Other conditions judged by the investigator to be unsuitable for participating in the study.

Design outcomes

Primary

MeasureTime frame
Blinking Undeturbed Tear Break-Up Time, BUT;Tears River Height;Degree of meibomian gland deficiency;

Secondary

MeasureTime frame
Dry Eye Questionnaire Score;

Countries

China

Contacts

Public ContactYu Jun

Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine

yujun801224@126.com+86 137 8892 8286

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 3, 2026